Accidents caused by Loxosceles spider may cause severe systemic reactions, including acute kidney injury (AKI). There are few experimental studies assessing Loxosceles venom effects on kidney function in vivo.
In order to test Loxosceles gaucho venom (LV) nephrotoxicity and to assess some of the possible mechanisms of renal injury, rats were studied up to 60 minutes after LV 0.24 mg/kg or saline IV injection (control). LV caused a sharp and significant drop in glomerular filtration rate, renal blood flow and urinary output and increased renal vascular resistance, without changing blood pressure. Venom infusion increased significantly serum creatine kinase and aspartate aminotransferase. In the LV group renal histology analysis found acute epithelial tubular cells degenerative changes, presence of cell debris and detached epithelial cells in tubular lumen without glomerular or vascular changes. Immunohistochemistry disclosed renal deposition of myoglobin and hemoglobin. LV did not cause injury to a suspension of fresh proximal tubules isolated from rats.
Loxosceles gaucho venom injection caused early AKI, which occurred without blood pressure variation. Changes in glomerular function occurred likely due to renal vasoconstriction and rhabdomyolysis. Direct nephrotoxicity could not be demonstrated in vitro. The development of a consistent model of Loxosceles venom-induced AKI and a better understanding of the mechanisms involved in the renal injury may allow more efficient ways to prevent or attenuate the systemic injury after Loxosceles bite.
Loxosceles (recluse or brown spider) is the most important spider genus causing human envenomation. In Brazil Loxosceles spiders were responsible for approximately 7,000 cases of spider envenomation per year. The brown spider accidents may cause late cutaneous necrosis at the bite site, intravascular hemolysis, rhabdomyolysis, coagulation system changes and acute kidney injury (AKI). Even patients with mild cutaneous lesion may develop severe hemolysis and AKI, which is the main cause of death after these accidents. The mechanisms causing kidney injury are poorly understood. In this manuscript we described a consistent rodent model of Loxosceles gaucho venom-induced AKI and studied some of the possible mechanisms of the renal lesion. The results of this research showed that kidney injury may occur independently of the cutaneous lesion and without changes in the systemic blood pressure. Kidney dysfunction occurred likely due to intra-renal vasoconstriction and rhabdomyolysis, although a direct toxic effect of the venom on the proximal tubules cannot be ruled out.
Citation: Lucato RV Jr, Abdulkader RCRM, Barbaro KC, Mendes GE, Castro I, Baptista MASF, et al. (2011) Loxosceles gaucho Venom-Induced Acute Kidney Injury – In Vivo and In Vitro Studies. PLoS Negl Trop Dis 5(5): e1182. doi:10.1371/journal.pntd.0001182
Editor: David G. Lalloo, Liverpool School of Tropical Medicine, United Kingdom
Received: December 16, 2009; Accepted: April 16, 2011; Published: May 31, 2011
Copyright: © 2011 Lucato Jr et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was partially supported by the State of Sao Paulo Research Foundation (FAPESP), Sao Paulo, Brazil. Dr. Emmanuel A. Burdmann, Dra Katia Cristina Barbaro and Dr. Nestor Schor are partially supported by grants from the National Council for Scientific and Technological Development (CNPq), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Loxosceles spiders can be found worldwide in temperate and tropical regions but their distribution is heavily concentrated in the Western Hemisphere , . In fact, in South America, loxoscelism is considered the most important form of araneism due to its high incidence and morbidity –. In Brazil, Loxosceles spiders were responsible for approximately 7,000 cases of spider envenomation reported to the Brazilian Ministry of Health in 2006 [Unpublished data. SINAN-Animais Peçonhentos/SVS/MS. http://dtr2004.saude.gov.br/sinanweb/tabnet/dh?sinan/animaisp/bases/animaisbr.def].
Loxosceles venom is a complex mixture of several proteins including alkaline phosphatase, hyaluronidase, 5-ribonucleotidase phosphohydrolase, sphingomyelinase D, several proteases, esterase and ATPase. Sphingomyelinase D is considered the most toxic fraction of the venom, playing a key role in its local and systemic action –. It causes neutrophil migration, complement system activation, cytokine and chemokine release and platelet aggregation .
Loxosceles spiders are not aggressive and the bites usually occur when they are pressed against the body, mainly while the victim is sleeping or dressing. The accident may cause mild cutaneous inflammatory reaction or a local injury characterized by pain, edema and livedo, developing later to dermonecrosis with gravitational spreading –. In up to 13% of the cases , loxoscelism can cause a systemic injury, known as viscerocutaneous loxoscelism (VCL). This form occurs predominantly in children , and patients may develop acute kidney injury (AKI), which is considered the main cause of death after loxoscelism envenomation , . VCL is characterized by fever, malaise, weakness, nausea and vomiting, hemolysis, hematuria, jaundice, thrombocytopenia and disseminated intravascular coagulation. This severe multisystemic clinical picture can occur as early as 24 hours after the bite –, .
AKI has been described in VCL as single case reports – or as relatively small series of cases –. Data on AKI after VCL are not consistent, even in the same country. Several factors might account for this, including the spider species and the patient age. In Brazil, 49% of AKI, 45.7% of oliguria and 8.6% of anuria were found among 35 VCL cases . On the other hand, among 359 cases treated in Butantan Institute, Brazil, 4% developed VCL and none presented AKI . In Chile, plasma creatinine was assessed in 26 of 34 VCL cases and was elevated in all, with values ranging from 4.4 to 6.0 mg/dL . In the USA, AKI was found in 1 of 6 children hospitalized due to VCL . These differences in AKI frequency can be due to the distribution of different Loxosceles species through the North and South Americas . In São Paulo the commonest specie is the Loxosceles gaucho but in other regions of Brazil the Loxosceles intermedia is the most prevalent. The mechanisms for Loxosceles venom-induced AKI are still elusive and renal injury has been attributed to hemolysis, rhabdomyolysis, shock and direct venom nephrotoxicity , , , , , –.
Few experimental studies have focused on the action of the Loxosceles venom in the kidney, and none have performed a detailed study on renal function and hemodynamics. The aim of the present study was to assess the nephrotoxicity of Loxosceles gaucho venom in rats and study some of the mechanisms possibly involved in the genesis of the renal injury.
Materials and Methods
Experiments were done according to the Brazilian law of protection of animals. The study was approved by the Animal Experimentation Ethics Committee (CEEA), FAMERP.
Specimens of L. gaucho were collected in São Paulo State. The spiders were kept in quarantine for one week without food before venom collection, and venoms were obtained as previously described . A pool of venom collected from approximately 1,000 L. gaucho spiders was used. The protein content of venom pool was determined using bicinchoninic acid .
In vivo experiments
Adult male Wistar rats weighing 150 to 270 g were housed in a temperature- and light-controlled environment. They received standard diet and were allowed free access to tap water.
Loxosceles gaucho venom (LV) was diluted in saline and infused (240 µg/kg) in the jugular vein at the rate of 0.06 mL/min (infusion pump, model 975, Harvard, USA). Control animals received the same volume of saline. The LV dose used was selected after pilot experiments beginning with 0.15 mg/kg that was the LD50 for mice after subcutaneous injection .
Glomerular filtration rate (GFR).
After anesthesia with intraperitoneal thiopental (50 mg/kg) tracheostomy was performed and a polyethylene tube (PE-50) was placed in a carotid artery. Mean carotid arterial blood pressure (BP) was continuously measured with an electronic transducer (P23 Db, Statham Instruments Division, Could Inc., Hato Rey, USA) connected to a digital polygraph (Blood Pressure Display Unit, Stoelting, USA) throughout the experiments. PE-50 tubes were also placed in both jugular veins and a polyethylene tube (PE-90) was placed and sutured in the bladder. Animals were maintained in a stable temperature (36.5±1°C) by a thermostatically controlled warming table (Braile Biomédica, São José do Rio Preto, Brazil). After surgery, a dose of 1 mL of inulin solution (300 mg of inulin in 12 mL of saline, Sigma Chemical Co., St. Louis, MO, USA) was given, followed by an infusion of the same solution at a rate of 0.06 mL/min (Harvard infusion pump model 975, USA). After a 60 min equilibration time, LV (venom, n = 8) or saline (control, n = 8) were infused as described above. After a 30 min equilibration time, urine was collected over two periods of 20 min each. A blood sample (0.3 mL) was drawn at the midpoint of each urine collection and replaced with an equal volume of saline. Inulin clearance values, expressed as mL/min/100 g body wt, represent the means of the two clearance periods. Diuresis (µL/min) was assessed by the weight difference in the collection vials before and after urine collection.
Renal blood flow (RBF).
Anesthesia, tracheostomy and carotid and jugular surgical preparation were performed as previously described. After that, a ventral midline incision was made, exposing the left renal artery, which was dissected and a suitable probe (R series, 1.5 mm, Transonic Systems, Ithaca, NY, USA) was placed around it. At this point LV (venom, n = 8) or saline (control, n = 8) were infused as already described, followed by maintenance infusion of saline at 0.06 mL/min (infusion pump, Harvard Apparatus, Holliston, MA, USA).
After a 60 min equilibration time, four ultrasonic RBF measurements were performed (T 106, Transonic Systems Inc, Ithaca, NY, USA) during 10 min observation period. RBF values represent the means of the four measurements. BP was continuously monitored as previously described. Renal vascular resistance (RVR) was calculated by the usual formula (BP/RBF).
Hemolysis and rhabdomyolysis evaluation.
Anesthesia, surgical preparation and venom (venom, n = 8) or saline (control, n = 8) infusion were carried out as previously described. After 60 minutes of equilibration period blood was collected for measurement of hematocrit (Hct), creatine kinase (CK), serum aspartate aminotransferase (AST), serum alanine aminotransferase (ALT) and lactic dehydrogenase (LDH).
The left kidney was collected at the end of GFR measurements in 6 rats injected with LV and 6 rats injected with saline. Renal tissue was fixed in 4% buffered formalin and embedded in paraffin. Horizontal sections 3 to 4 µm thick were stained with periodic acid-Schiff's reagent (PAS), hematoxylin-eosin, Masson trichrome and periodic acid methenamine silver. The tissue was evaluated by light microscopy by two observers masked to the treatment. Tubular, vascular and glomerular changes were evaluated according a 0 to 3 semiquantitative score. In the vessels and glomeruli, signs of endothelial injury (fibrin thrombi in glomerular capillary lumina, disruption or reduplication of the glomerular capillary basement membrane, swollen endothelial cells and fibrinoid necrosis) were extensively searched.
Sections from representative formalin-fixed paraffin embedded samples were stained with monoclonal antibody against hemoglobin and myoglobin, with amplification by streptavidin-peroxidase method. Briefly, after deparaffinization in xylene and rehydration in graded ethanol, antigen epitope retrieval was performed using 10 mM citric acid solution, pH 6.0 in a pressure cooker. Endogenous peroxidase activity was blocked with 6% hydrogen peroxide for 20 min.
Primary mouse Polyclonal Rabbit Anti-human Hemoglobin antibody (code # A0118, DakoCytomation, USA), diluted 1∶1000, and Sheep Anti-human Myoglobin (code # PH 213, The Binding Site, USA), diluted 1∶50, were incubated for 30 min at 37°C followed by overnight incubation at 4°C, and then by addition of biotinylated anti-mouse secondary antibody and streptavidin-horseradish peroxidase (LSAB+, code # k0690, Dako, Carpinteria, CA, USA).
Color of reaction product was developed by 3,3′-diaminobenzidine and H2O2 and counterstaining was performed with Harris hematoxylin. The primary antibody was omitted for negative controls and endothelial cells of tonsil were used as positive control. The immuno-expression of hemoglobin and myoglobin was evaluated in a semi-quantitative approach. Samples with no evidence of staining or those with evidence of only focally positive cells (<1%) were recorded as negative.
In vitro experiments
Proximal tubule injury.
Isolation of proximal tubules (PT): male Wistar rats were anesthetized with sodium thiopental (40 mg/kg i.p.). PT were isolated by collagenase digestion and Percoll gradient as previously described .
PT toxicity protocol: LV venom concentrations of 3.17 and 6.34 µg/mL were added at baseline to oxygenated PT suspensions and kept for 60 min.
Cell injury: Cell injury was assessed by LDH release. LDH was measured after removal of 1 mL sample from tubules suspension (venom and time control groups) at baseline and after 60 min. LDH release was calculated by dividing supernate LDH by total LDH (supernate + pellet) and expressed as a percentage (n = 5).
Inulin was determined by chemical anthrone method. CK, AST, ALT and LDH were assessed by colorimetry (Hitachi auto-analyzer model 917, Japan). Hct was assessed by a microhematocrit method.
Results are presented as mean ± standard error of mean (SEM). Comparisons were done by two-tail unpaired Student's t-test or one-way ANOVA, as appropriate. P values<0.05 were considered significant.
Renal function and hemodynamics
Loxosceles gaucho venom caused an early and significant decrease in GFR and urinary volume. In the same way, venom caused a sharp and significant decrease in RBF and a significant RVR increase. These changes occurred without significant variation in BP. In the control group saline infusion did not change GFR, RBF and RVR, urinary volume or blood pressure (see table1).
Direct tubular toxicity
Loxosceles gaucho venom did not cause cellular injury to PT in both concentrations utilized. After 60 min LDH release was 21.2±0.4% in control, 22.0±1.0% in LV 3.17 µg/mL and 22.4±0.5% in LV 6.34 µg/mL.
Enzymes and hematocrit
Loxosceles gaucho venom induced a statistically significant increase in serum CK and AST as compared to control group. LDH and ALT values also increased in the venom group, but the difference was not statistically significant when compared to saline-infused rats. Hematocrit values were similar in venom and control groups (see table 1).
In the LV group, rats showed flattened epithelium (score 1.3±0.2), tubule dilatation (score 1.8±0.3), presence of cell debris in tubular lumen (score 1.25±0.25) presence of detached epithelial cells in tubular lumen (score 1.2±0.2) and acute epithelial degenerative changes (score 1.6±0.3). In the control group, animals showed normal renal histology. Endothelial injury was not found in any animal. All glomerular capillaries showed patent lumina and preserved endothelial cells.
The control group showed negative myoglobin immunostaining in all rats. In the LV group, three animals presented focal myoglobin deposition (1+), one animal disclosed focal and interstitial myoglobin staining (1+), one animal showed interstitial myoglobin deposition (2+) and one animal did not present myoglobin at renal tissue.
In the control group two animals presented focal hemoglobin staining (1+) and four animals were negative for hemoglobin. In the LV group, four animals showed focal hemoglobin staining (1+), one animal showed (3+) of hemoglobin deposition, and one animal did not present hemoglobin at renal tissue.
These data are represented at Figure 1.
A. Negative staining for myoglobin (200 X). B. Positive tubular cytoplasm staining for myoglobin (black arrows). Note tubular necrosis in the same area (200 X). C. Negative staining for hemoglobin (200 X). D. Positive tubular cytoplasm staining (black arrows) for hemoglobin (200 X).
An important and novel result from this study is the finding that Loxosceles gaucho venom may produce renal damage and rhabdomyolysis independently from the dermonecrotic injury or to blood pressure changes. The factors most likely contributing for the observed renal injury were renal vasoconstriction and myoglobinuria. In a consistent way with the available clinical results , , ,  and to data originated from experimental studies in mice , , , renal histology disclosed acute tubular necrosis.
There was an early and intense RBF decrease and RVR increase in venom-infused animals. Loxosceles venom may cause intravascular clotting and consequently tissue ischemia , , but this phenomenon was not observed in the present study. Other mechanisms possibly related to LV-induced decrease in RBF are the venom toxicity to endothelial cells , its property to degrade extracellular matrix molecules acting against basement membrane structures  and its vasoconstrictive activity . Contrasting with the findings of an experimental model that utilized Loxosceles intermedia venom , no signs of endothelial injury were found in the present study, in which Loxosceles gaucho venom was used. These differences might explain the variation in lethality of the venom of diverse Loxosceles species. In fact, Loxosceles intermedia venom is more lethal than Loxosceles gaucho venom .
Rhabdomyolysis has been sporadically related after human loxoscelism , , . Although only low myotoxicity activity was reported in experimental studies with LV , , the venom clearly caused rhabdomyolysis in the current experiment, as evidenced by significant CK increase and deposition of myoglobin in renal tissue. It is noteworthy that rhabdomyolysis was caused by a systemic venom effect, totally independent from local injury, which actually did not exist in the present model. Rhabdomyolysis is a well known cause of AKI, causing direct injury to tubule cells and inducing or enhancing vasoconstriction .
Loxosceles envenomation has been associated to hemolysis in humans , , . Although there was no hematocrit decrease in the venom-infused rats, renal tissue stained positively for hemoglobin after venom infusion and LDH was three times higher in the venom as compared to the control group. Even considering that this difference was not statistically different, it is possible that some degree of hemolysis had occurred, contributing for the renal injury genesis.
The early development of renal dysfunction, the low molecular weight and the cationic charge of the venom components, facilitating its renal excretion, suggest that LV might have a potential direct toxic effect on tubule cells. In fact, Luciano et al.  showed L. intermedia venom binding at glomerular and tubule cells basement membranes of mice with venom-induced AKI. Considering that this venom is capable to damage the basement membrane, a direct nephrotoxicity effect may have contributed to AKI development in these mice. Chaim et al.  demonstrated the deposit and binding of the dermonecrotic fraction of L. intermedia venom to renal intrinsic structures of mice with LV-induced renal injury. When the venom was added to a MDCK cell culture, it deposited in the cells surface and caused cells structural changes, impaired spreading and cells adhesion and altered cell viability. The current results are discordant with this previous paper, since Loxosceles venom did not cause direct toxicity in proximal tubules suspension. However, there are some possible explanations for this difference. While Chaim et al. , used cultured MDCK cells, we used fresh prepared proximal tubules suspension from rats. The spider species utilized were different, L. gaucho in the present experiment versus L. intermedia in the other cited studies , . Finally, it is possible that the venom needs plasma components, such as complement, not present in our experimental preparation, in order to cause proximal tubule cell toxicity.
There is just another study assessing the effects of Loxosceles venom in vivo, which was performed in mice . The authors didńt measure glomerular filtration rate, systemic and renal hemodynamic were not assessed, neither muscle enzymes measured. They found blood urea elevation four hours after intraperitoneal injection of crude L. intermedia venom. There was no hemolysis and renal histology analysis disclosed glomerular collapse and loss of vascular integrity and tubule cell injury. In a subsequent study, the same group demonstrated that the intraperitoneal injection of the dermonecrotic fraction of the venom in mice caused nephrotoxicity similar to that seen with the crude venom .
In summary, intravenous injection of Loxosceles gaucho venom induced a striking acute kidney injury, without dermonecrotic lesion or variations in systemic blood pressure. The observed renal changes were associated to impaired renal blood flow and systemic rhabdomyolysis. Although a direct venom effect on isolated proximal tubules was not demonstrated, venom direct nephrotoxicity cannot be totally ruled out.
Conceived and designed the experiments: EAB RCRMA LY NS KCB. Performed the experiments: RVL GEM IC. Analyzed the data: EAB RCRMA LY NS KCB RVL GEM IC MASFB PMC DMCM. Contributed reagents/materials/analysis tools: EAB LY KCB MASFB PMC DMCM. Wrote the paper: EAB RCRMA LY NS KCB.
- 1. Hogan CJ, Barbaro KC, Winkel K (2004) Loxoscelism: old obstacles, new directions. Ann Emerg Med 44: 608–624.
- 2. Swanson DL, Vetter RS (2006) Loxoscelism. Clin Dermatol 24: 213–221.
- 3. da Silva PH, da Silveira RB, Appel MH, Mangili OC, Gremski W, et al. (2004) Brown spiders and loxoscelism. Toxicon 44: 693–709.
- 4. Barbaro KC, Knysak I, Martins R, Hogan C, Winkel K (2005) Enzymatic characterization, antigenic cross-reactivity and neutralization of dermonecrotic activity of five Loxosceles spider venoms of medical importance in the Americas. Toxicon 45: 489–499.
- 5. Abdulkader RCRM, Barbaro KC, Barros EJG, Burdmann EA (2008) Nephrotoxicity of insect and spider in Latin America. Sem Nephrol 28: 373–382.
- 6. Sezerino UM, Zannin M, Coelho LK, Gonçalves Júnior J, Grando M, et al. (1998) A clinical and epidemiological study of Loxosceles spider envenoming in Santa Catarina, Brazil. Trans R Soc Trop Med Hyg 92: 546–548.
- 7. de Souza AL, Malaque CM, Sztajnbok J, Romano CC, Duarte AJ, et al. (2008) Loxosceles venom-induced cytokine activation, hemolysis, and acute kidney injury. Toxicon 51: 151–156.
- 8. Maya Rodriguez LE (1964) Hemodialysis with artificial kidney in the treatment of acute renal insufficiency from Loxoscelism. An Fac Med Lima 47: 419–439.
- 9. Taylor EH, Denny WF (1966) Hemolysis, renal failure and death, presumed secondary to bite of brown recluse spider. South Med J 59: 1209–1211.
- 10. Salazar E, Velásquez L, Caravedo L, Schoemaker E, Zegarra O, et al. (1978) Acute renal insufficiency after a bite by the Loxosceles spider. Pediatria 21: 337–346.
- 11. Zambrano A, Gonzalez J, Callejas G (2005) Severe loxoscelism with lethal outcome. Report of one case. Rev Med Chil 133: 219–223.
- 12. Campalans LA, Rodríguez L, Llopart T, Acosta W, Witkind J, et al. (1973–1974) Insuficiencia renal aguda por mordedura de araña (a propósito de tres casos de loxoscelismo). Rev Urug Patol Clín Microbiol 11-12: 13–24.
- 13. Gonzalez C, Saffie A, Fardella C, Contreras A (1986) Acute renal failure in viscerocutaneous loxoscelism: 11 cases. Rev Med Chil 114: 1155–1159.
- 14. França FO, Barbaro KC, Abdulkader RC (2002) Rhabdomyolysis in presumed viscero-cutaneous loxoscelism: report of two cases. Trans R Soc Trop Med Hyg 96: 287–290.
- 15. Málaque CMSA, Castro-Valencia JE, Cardoso JLC, França FOS, Barbaro KC, et al. (2002) Clinical and epidemiological features of definitive and presumed loxoscelism in São Paulo, Brazil. Rev Inst Med trop S Paulo 44: 139–143.
- 16. Schenone FH, Saavedra T, Rojas A, Villarroel F (1989) Loxoscelismo en Chile. Estudios epidemiologicos, clinicos y experimentales. Rev Inst Med Trop São Paulo 31: 403–415.
- 17. Elbahlawan LM, Stidham GL, Bugnitz MC, Storgio SA, Quasney MW (2005) Severe systemic reaction to Loxosceles reclusa spider bites in a pediatric population. Pediatr Emerg Care 21: 177–180.
- 18. Luciano MN, da Silva PH, Chaim OM, dos Santos VL, Franco CR, et al. (2004) Experimental evidence for a direct cytotoxicity of Loxosceles intermedia (brown spider) venom in renal tissue. J Histochem Cytochem 52: 455–467.
- 19. Chaim OM, Sade YB, da Silveira RB, Toma L, Kalapothakis E, et al. (2006) Brown spider dermonecrotic toxin directly induces nephrotoxicity. Toxicol Appl Pharmacol 211: 64–77.
- 20. Barbaro KC, Cardoso JLC, Eickstedt VRD, Mota I (1992) Dermonecrotic and lethal components of Loxosceles gaucho spider venom. Toxicon 30: 331–338.
- 21. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, et al. (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150: 76–85.
- 22. Domingos MO, Barbaro KC, Tynan W, Penny J, Lewis DJM, et al. (2003) Influence of sphingomyelin and TNF-alfa release on lethality and local inflammatory reaction induced by Loxosceles gaucho spider venom in mice. Toxicon 42: 471–479.
- 23. de Castro I, Burdmann EA, Seguro AC, Yu L (2004) Bothrops venom induces direct renal tubular injury: role for lipid peroxidation and prevention by antivenom. Toxicon 43: 833–839.
- 24. Schenone FH, Rubio AS, Saavedra UT, Rojas SA (2001) Loxoscelismo en pediatría: Región Metropolitana, Chile. Rev Chil Pediatr 72: 100–109.
- 25. Schenone FH (2003) Cuadros tóxicos producidos por mordeduras de araña en Chile: latrodectismo y loxoscelismo. Rev Med Chile 131: 437–444.
- 26. Tambourgi D, Petricevich V, Magnoli F, Assaf S, Jancar S, et al. (1998) Endotoxemic-like shock induced by spider venoms: pathological changes and putative cytokine mediators. Toxicon 36: 391–403.
- 27. Tavares FL, Sousa-e-Silva MC, Santoro ML, Barbaro KC, Rebecchi IM, et al. (2004) Changes in hematological, hemostatic and biochemical parameters induced experimentally in rabbits by Loxosceles gaucho spider venom. Hum Exp Toxicol 23: 477–486.
- 28. Van den Berg CW, Goncalves de Andrade RM, Magnoli FC, Tambourgi DV (2007) Loxosceles spider venom induces the release of thrombomodulin and endothelial protein C receptor: implications for the pathogenesis of intravascular coagulation as observed in loxoscelism. J Thromb Haemost 5: 989–995.
- 29. Paludo KS, Gremski LH, Veiga SS, Chaim OM, Gremski W, et al. (2006) The effect of brown spider venom on endothelial cell morphology and adhesive structures. Toxicon 47: 844–853.
- 30. Veiga SS, Feitosa L, dos Santos VL, de Souza GA, Ribeiro AS, et al. (2000) Effect of brown spider venom on basement membrane structures. Histochem J 32: 397–408.
- 31. Barbaro KC, Ferreira ML, Cardoso DF, Eickstedt VRD, Mota I (1996) Identification and neutralization of biological activities in the venoms of Loxosceles spiders. Braz J Med Biol Res 29: 1491–1497.
- 32. Ospedal KZ, Appel MH, Neto JF, Mangili OC, Veiga SS, et al. (2002) Histopathological findings in rabbits after experimental acute exposure to the Loxosceles intermedia (brown spider) venom. Int J Exp Pathol 84: 287–292.
- 33. Vanholder R, Erek MS, Erek S, Lameire N (2000) Rhabdomyolysis. J Am Soc Nephrol 11: 1553–1561.
- 34. McDade J, Aygum B, Ware RE (2010) Brown reclusa spider (Loxosceles reclusa) envenomation leading to acute hemolytic anemia in six adolescents. J Pediatr 156: 155–157.